December 03, 2024
Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress syndrome in newborn infants with few, if any, options for long-term survival Highly encouraging preclinical data highlight the possibility of lifelong treatment from a single administration of AVG-002 with preparations for clinical...
Continue ReadingAugust 10, 2020
As novel coronavirus cases continue to increase in the United States and throughout the world, the , in collaboration with , is raising funds for research to bring an end to the COVID-19 pandemic.Officials confirm the money will support Harrington’s COVID-19 Rapid Response Initiative to provide critical funding to selected... Continue Reading
July 21, 2020
New York/Cleveland, OH, July 21, 2020 – A licensing agreement between drug maker Acadia Pharmaceuticals and Vanderbilt University represents a major milestone for the ADDF-Harrington Scholar Award Program, which provided funding and pharmaceutical expertise to support the research in the early phases. Acadia and Vanderbilt... Continue Reading
July 15, 2020
July 15, 2020, CLEVELAND, Ohio USA – National and international nominations are being sought for the 2021 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application. The deadline... Continue Reading
July 08, 2020
NEW YORK, NY, July 8, 2020 – The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals have granted , of Mayo Clinic Rochester, an .Dr. Trushina has been awarded $600,000 for her late stage preclinical research on new drug candidates that show promise in restoring... Continue Reading
July 08, 2020
July 8, 2020, CLEVELAND and NEW YORK CITY – Coronavirus cases continue to increase in the United States and throughout the world. Harrington Discovery Institute at University Hospitals, in collaboration with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, is raising funds for research to bring an end to the COVID-19... Continue Reading
June 19, 2020
When a research project over 15 years in the making resulted in a drug that improved pulmonary function and oxygen delivery, researcher James D. Reynolds thought the drug could also help COVID-19 patients with severely compromised lung and heart function. Reynolds, Professor of Anesthesiology & Perioperative Medicine, was... Continue Reading
June 11, 2020
June 11, 2020, CLEVELAND, Ohio USA – The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, in collaboration with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, today announced 12 award winners in the COVID-19 Rapid Response Initiative. These award recipients will receive grant funding and... Continue Reading
April 16, 2020
2020 Harrington Prize for Innovation in Medicine Recognizes Contributions to Red Blood Cell Biology Continue Reading
April 07, 2020
April 7, 2020, CLEVELAND, Ohio USA - The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today issued a transatlantic call for proposals for new treatments, pursuant to its to support the global fight against novel Coronavirus and potential future pandemic events. Harrington Discovery Institute (HDI)... Continue Reading
April 02, 2020
April 2, 2020, CLEVELAND, Ohio USA –The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, announced today a new initiative that galvanizes its transatlantic network of academic institutions, foundations, and philanthropic partners to accelerate promising, near-term therapies to treat COVID-19 and its... Continue Reading